BLOG

NK Cell Therapy After Cancer Treatment: What to Know in Osaka

Published 2026.10.12 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

After cancer treatment ends, many people ask a quiet but important question: what can I do now to look after my body and my immune system? Some international patients and residents of Japan hear about NK cell therapy in this context, often described as an option aimed at recurrence prevention or immune health maintenance. This article explains what that phrase can and cannot mean, so you can prepare better questions before a consultation at Grand Green Osaka Umekita Clinic or any other clinic.

In short: NK cell therapy is a self-funded (non-insurance) option that uses your own immune cells. It is not a replacement for follow-up care with your oncology team, and whether it suits you is a decision to make with a doctor after an individual consultation.

What does “recurrence prevention” mean in this context?

Cancer treatments such as surgery, chemotherapy and radiation therapy are designed to remove or reduce tumors. Even after a successful course of standard treatment, some people worry that a small number of abnormal cells may remain or that new ones may appear later. This worry is understandable, and it is the reason follow-up visits, imaging and blood tests are scheduled by your treating team.

When a clinic describes NK cell therapy as being received “with the aim of” preventing recurrence, it describes the purpose of the approach, not a promised result. No therapy can promise that cancer will not return, and a careful clinic should say so clearly. The treatment is better understood as an additional option that some patients consider alongside, not instead of, their regular medical follow-up.

How NK cells relate to immune surveillance

NK (natural killer) cells are a type of lymphocyte that circulates in the blood. They are part of the innate immune system and can recognize and attack abnormal cells, including cancer cells and virus-infected cells, without waiting for instructions from other immune cells.

Researchers use the term immune surveillance for the idea that the immune system continually finds and removes abnormal cells before they grow. NK cell activity has been reported to decline with age, stress and the effects of cancer itself. The rationale behind NK cell therapy is to return a larger number of more active NK cells, with the aim of reinforcing immune function that may have weakened. Published research on NK cells in cancer is active, but results vary by cancer type, cell preparation method and patient condition, so findings from one study should not be generalized to every person.

How the treatment process works

The therapy uses your own (autologous) cells. The general flow is simple to describe:

A standard blood draw is taken at the clinic.
NK cells are activated and expanded at a licensed cell processing facility.
The cultured cells are returned to your body by intravenous (IV) infusion, without hospitalization.

Because it relies on a blood draw and an IV drip, many patients find the process physically gentle compared with other cancer treatments. Even so, temporary reactions such as fever or fatigue can occur, and any treatment carries risks. Your doctor should explain the possible side effects, what to do if symptoms appear, and how the schedule fits around your other appointments.

Using it alongside standard care and follow-up

NK cell therapy may be considered alongside surgery, chemotherapy or radiation therapy, but whether and when it fits with your treatment should be confirmed with your doctors. For someone who has finished active treatment, it may be discussed as a way to support immune health during the follow-up period. The most important point is that it should never lead you to skip scheduled check-ups, scans or advice from your oncologist.

If you are an international patient, it helps to bring your diagnosis summary, treatment history, recent test results and a list of current medications, ideally with an English translation. With your permission, the clinic can coordinate with the medical institution providing your standard treatment, which helps keep everyone informed about what you are receiving.

Regulation, cost and limits you should understand

In Japan, NK cell therapy is provided as a self-funded treatment, which means it is not covered by national health insurance. It is delivered under the Act on the Safety of Regenerative Medicine, through a treatment plan submitted to and accepted by the relevant authority. This framework is part of how quality and oversight are managed, but it is not a statement that the treatment is effective for any individual.

Costs, number of sessions, treatment period, risks, side effects and whether you are a suitable candidate can only be confirmed by a doctor after a consultation. Be cautious about any information source that presents immune cell therapy as a sure way to prevent recurrence, or that suggests it can replace standard treatment.

Questions to bring to your consultation in Osaka

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, and multilingual information pages are available for international patients. Before you book, it can help to prepare questions such as these:

What exactly is the goal of treatment in my situation, and how will it be described honestly given the limits of the evidence?
How does this fit with my oncologist’s follow-up plan, and can you coordinate with them?
What are the total costs, the number of infusions and the expected timeline if I travel from overseas?
What temporary reactions or risks should I be aware of, and who do I contact after I return home?
Under which regenerative medicine provision plan is the treatment provided?

A clear conversation on these points will help you decide whether to proceed, wait or choose another path. Asking questions is a normal part of the process, and a good clinic will welcome them.

Key takeaways

NK cell therapy for recurrence prevention or immune health maintenance is best viewed as a self-funded, individually assessed option that works with your own immune cells. It does not promise that cancer will not return, and it does not replace standard care or regular follow-up. If you are considering it, use the multilingual resources and a doctor’s consultation at Grand Green Osaka Umekita Clinic to review fees, risks, side effects and suitability before making a decision.

Before You Consider NK Cells

Uses your own immune cells
Alongside standard careFollow-up still matters
Confirm fees and risksDecided with a doctor
Plan from overseas

This figure is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›